ET
BLTE

Entropy Technologies’s Belite Bio BLTE Stock Holding History

Entropy Technologies’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$570K Buy
+3,700
New +$567K 0.02% 639

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Entropy Technologies's BLTE Position: Q2 2026 in Review

Entropy Technologies opened a new position in Belite Bio (BLTE) in Q2 2026: 3,700 shares worth $570K. The stake represents 0.02% of the portfolio and ranks #639 among its holdings.

81 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • Entropy Technologies held 3,700 shares of Belite Bio worth $570K as of Q2 2026.
  • Belite Bio was a new Entropy Technologies position in Q2 2026.
  • Belite Bio made up 0.02% of Entropy Technologies's portfolio in Q2 2026, its #639 holding.
  • 81 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.